Ulusan, M. Et Al. 2022. The let-7 microRNA binding site variant in KRAS as a predictive biomarker for head and neck cancer patients with lymph node metastasis. Pathology Research and Practice , vol.239 .

Ulusan, M., Şen, S., Yilmazer, R., Dalay, N., & Demokan, S., (2022). The let-7 microRNA binding site variant in KRAS as a predictive biomarker for head and neck cancer patients with lymph node metastasis. Pathology Research and Practice , vol.239.

Ulusan, Murat Et Al. "The let-7 microRNA binding site variant in KRAS as a predictive biomarker for head and neck cancer patients with lymph node metastasis," Pathology Research and Practice , vol.239, 2022

Ulusan, Murat Et Al. "The let-7 microRNA binding site variant in KRAS as a predictive biomarker for head and neck cancer patients with lymph node metastasis." Pathology Research and Practice , vol.239, 2022

Ulusan, M. Et Al. (2022) . "The let-7 microRNA binding site variant in KRAS as a predictive biomarker for head and neck cancer patients with lymph node metastasis." Pathology Research and Practice , vol.239.

@article{article, author={Murat ULUSAN Et Al. }, title={The let-7 microRNA binding site variant in KRAS as a predictive biomarker for head and neck cancer patients with lymph node metastasis}, journal={Pathology Research and Practice}, year=2022}